Mol Imaging Radionucl Ther. 2012 Dec;21(3):103-9. doi: 10.4274/Mirt.25744. Epub 2012 Dec 20.

The Effects of the Factors Related to the Patient and the Disease on the Performance of Ablation Therapy in Patients with Differentiated Thyroid Cancer who have Received I-131 Ablation Therapy.

Molecular imaging and radionuclide therapy

Tarık Sengöz, Erdem Sürücü, Yusuf Demir, Erkan Derebek

PMID: 23487510 PMCID: PMC3590978 DOI: 10.4274/Mirt.25744

Abstract

OBJECTIVE: To investigate whether the factors related to the patient and the disease have any effect on the success of ablation therapy in patients with differentiated thyroid cancer who have received I-131 ablation therapy.

MATERIAL AND METHODS: All the patients with differentiated thyroid cancer were referred for I-131 ablation therapy after thyroidectomy between July 2007 and September 2009. The patients had at least six months of follow-up. Age, gender, type of tumor, presence of capsule invasion, size of tumor, number of the tumors, localization of the tumor, invasion of thyroid capsule, lymph/vessel invasion, presence of metastatic lymph nodes, type of surgery, preablation values of thyroglobulin (Tg), AntiTg, TSH, surveys for the evaluation of metastatic disease, (thyroid and bone scintigraphy, neck and abdominal ultrasonography, chest and brain computerized tomography), administered dose, postablation I-131 whole body scan (WBS) and diagnostic I-131 WBS, neck USG, values of Tg and AntiTg at the 6th month were recorded. The presence of residual thyroid activity on the 6th month diagnostic I-131 WBS image was accepted as the criterion for ablation success.

RESULTS: 191 patients with differentiated thyroid cancer were assessed in this study. The overall success rate of the first ablation therapy was 74.3%. The success rate of the ablation therapy was 66% and 75% in metastatic group and non-metastatic group, respectively. Except the significant correlation between the number of pathologic lymph nodes and the success of ablation (p=0.025), there was no other significant correlation between the patient/disease related factors and the success of ablation therapy.

CONCLUSION: Significant correlation between the number of the pathologic lymph nodes and the ablation therapy performance can also be due to statistical error because of the limited sample size. There was no significant correlation between other patient/disease related prognostic factors and the success of ablation therapy.

CONFLICT OF INTEREST: None declared.

Keywords: Iodine radioisotopes; Thyroid neoplasms; prognosis

References

1. Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S479-85 - PubMed
2. Nucl Med Commun. 2006 Aug;27(8):627-32 - PubMed
3. J Clin Endocrinol Metab. 1990 Aug;71(2):414-24 - PubMed
4. Endocrinol Metab Clin North Am. 1995 Dec;24(4):841-63 - PubMed
5. Cancer Control. 2000 May-Jun;7(3):229-39 - PubMed
6. Am J Med. 1994 Nov;97(5):418-28 - PubMed
7. J Nucl Med. 1993 Nov;34(11):1927-30 - PubMed
8. Cancer. 1996 Jun 15;77(12):2574-80 - PubMed
9. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1330-6 - PubMed
10. N Engl J Med. 1998 Jan 29;338(5):297-306 - PubMed
11. J Clin Endocrinol Metab. 2007 Sep;92(9):3542-6 - PubMed
12. Br J Radiol. 1998 Mar;71(843):307-13 - PubMed
13. J Clin Endocrinol Metab. 2002 Sep;87(9):4063-8 - PubMed
14. J Clin Endocrinol Metab. 2001 Apr;86(4):1447-63 - PubMed
15. Clin Endocrinol (Oxf). 2002 Oct;57(4):523-7 - PubMed
16. Endocrinol Metab Clin North Am. 1990 Sep;19(3):545-76 - PubMed
17. Ann Surg Oncol. 2012 Mar;19(3):990-5 - PubMed
18. Nucl Med Commun. 1988 Apr;9(4):262-6 - PubMed
19. Eur J Nucl Med. 1997 Jul;24(7):722-7 - PubMed
20. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):784-95 - PubMed

Publication Types

• Journal Article